Search results
What Is the First Line of Treatment for Multiple Sclerosis?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Lindsay Cook, PharmD In multiple sclerosis (MS), the immune system attacks the...
Top-Notch Biotech TG Therapeutics Breaks Out On 'Solid Jump' In Sales
Investor's Business Daily· 1 year agoTG Therapeutics' new multiple sclerosis drug, Briumvi, experienced a "solid jump" in March sales,...
Novartis says operating profit to grow again ahead of Sandoz spin-off
Reuters via Yahoo Finance· 1 year agoNovartis on Wednesday predicted that core operating income would grow in a "mid single digit"...
Novartis lifts 2023 earnings forecast for third time
Reuters via Yahoo News· 6 months agoBy Ludwig Burger FRANKFURT (Reuters) -Switzerland's Novartis on Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and...
Can People With MS Get the COVID-19 Vaccine?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Geetika Gupta, MD In some people with multiple sclerosis (MS), certain vaccines can trigger symptom flare-ups. This leads some...
Experimental Therapies for Multiple Sclerosis (MS)
Verywell Health via Yahoo News· 2 years agoThe goal of multiple sclerosis (MS) treatment is to slow or stop the immune system's attack on the nervous system. This article reviews the latest...
Race to Erase MS Celebrates 30th Anniversary Amid Hopeful Medical Advances
The Hollywood Reporter via Yahoo News· 11 months agoWhen philanthropist and jewelry designer Nancy Davis founded Race to Erase MS 30 years ago, the...
Novartis raises sales growth target to 5% a year through 2027
Reuters via Yahoo News· 5 months agoFRANKFURT (Reuters) -Novartis has dialled up its sales growth target to 5% per year until 2027,...